...
【24h】

Isolation of multiple cell-binding ligands from different phage displayed-peptide libraries

机译:从不同噬菌体展示肽库中分离出多种细胞结合配体

获取原文
获取原文并翻译 | 示例
           

摘要

A technical challenge in the development of biosensor devices for cancer detection and diagnosis is the identification of ligands that recognize cancer cells with high affinity and specificity. Furthermore, it is unlikely that one cell-binding ligand will provide sufficient biological information, thus, multiple ligands for a given cancer type will be needed for confident clinical diagnosis. Biopanning of phage displayed peptide libraries is a route to isolation of specific cell-binding reagents. A potential approach towards isolation of multiple ligands for a single cell type is to pan against the same cell type using different peptide libraries. Here we report the synthesis of a new 20-mer peptide-phage library and its use to select a peptide that binds to the large cell lung carcinoma cell line, HI299. The isolated phage clone binds H 1299 cells 80 times better than a control phage and can distinguish between H 1299 and normal control cells. The phage clone also binds to the lung pleura epidermoid cell line, Calu-1 but not to all lung carcinoma cell lines. The peptide is functional outside the context of the phage and tetramerization of the peptide on a trilysine core improves the affinity of the peptide. The tetrameric peptide can be used to deliver a fluorescent quantum dot to H1299 cells. Unexpectedly, the peptide shares sequence similarity to a previously isolated H1299-binding peptide isolated from a different 20-mer peptide library. Data suggests that the two peptides target the same cellular receptor. Our results imply that cell-based biopanning can isolate cell-binding ligands that may be of utility for cancer diagnosis, and isolation of cell-targeting peptides from different peptide libraries can expand the repertoire of cell-binding reagents. (c) 2005 Elsevier B.V. All rights reserved.
机译:在用于癌症检测和诊断的生物传感器装置的开发中的技术挑战是识别以高亲和力和特异性识别癌细胞的配体。此外,一个细胞结合配体不可能提供足够的生物学信息,因此,对于给定的癌症类型,需要多个配体来进行可靠的临床诊断。噬菌体展示的肽库的生物淘选是分离特定细胞结合试剂的途径。分离单个细胞类型的多个配体的潜在方法是使用不同的肽库针对同一细胞类型进行抗性筛选。在这里,我们报告了新的20-mer肽噬菌体文库的合成及其用于选择与大细胞肺癌细胞系HI299结合的肽的用途。分离的噬菌体克隆结合H 1299细胞的能力比对照噬菌体高80倍,并且可以区分H 1299和正常对照细胞。噬菌体克隆还结合肺胸膜表皮样细胞系Calu-1,但不结合所有肺癌细胞系。该肽在噬菌体的范围外具有功能,并且该肽在三赖氨酸核心上的四聚化改善了该肽的亲和力。四聚体肽可用于将荧光量子点递送至H1299细胞。出乎意料的是,该肽与从不同的20-mer肽库中分离的先前分离的H1299结合肽具有相似的序列。数据表明这两种肽靶向相同的细胞受体。我们的结果表明,基于细胞的生物淘选可以分离可能对癌症诊断有用的细胞结合配体,并且从不同的肽库中分离出靶向细胞的肽可以扩大细胞结合试剂的种类。 (c)2005 Elsevier B.V.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号